Oleylamine (9-octadecenylamine, ODA) Test Results
|
||||||||||||||||||||||||||||||||||||||||
ITC Designation -Thirteenth Report
48 FR 55674; December 14, 1983
Proposed Test Rule (PRM)
49 FR 45610; November 19, 1984
Final Test Rule (FRM)
52 FR 31962; August 24, 1987
CMA Oleylamine Program Panel (OPP)
Proposed Test Rule/Test Standards (PRMT)
52 FR 31970; August 24, 1987
Final Test Rule/Test Standards (FRMT)
53 FR 48542; December 1, 1988
Modifications
55 FR 12639; April 5, 1990/Test Standards
Project Manager: R. Sanford; J. Harris; R. Jones
Section Chief: R. Northrop
Status: Closed. All required tests have been completed. Test results have been forwarded to the Risk Assessment Division for review and disposition.
Identification of Chemicals
The term "ODA" refers to the substance, 9octadecenylamine. "Oleylamine" refers to commercial fatty amine mixtures containing 6576% ODA.
Announced Receipt of Test Data
The CMA submitted the results of a dermal toxicity range-finding study, a Salmonella mutagenicity assay (Ames test), and a chromosomal aberration assay in CHO cells (50 FR 31919; August 7, 1985) and a CHO/HGPRT mutation assay (50FR 46699; November 12, 1985). These submissions were part of a voluntary testing program.
A CMA submission of a mouse lymphoma mutagenesis assay was announced (54 FR 43482; October 25, 1989).
CMA submitted acute in vivo cytogenetics assay (mouse) and teratology studies (rats and rabbits) (54 FR 52449; December 21, 1989).
![[logo] US EPA](http://www.epa.gov/epafiles/images/logo_epaseal.gif)